Loading comparison data...
Compare DULAGLUTIDE (TRULICITY) and Metformin (Glucophage) — clinical data, side effects, and patient experiences.
TRULICITY, Trulicity · GLP-1 Agonist
How it works
12.1 Mechanism of Action TRULICITY contains dulaglutide, which is a human GLP-1 receptor agonist with 90% amino acid sequence homology to endogenous human GLP-1 (7-37). Dulaglutide...
Approved for
Glucophage, Fortamet, Glumetza · Biguanide
How it works
Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Approved for
Estimated frequency (%) based on clinical trial data
Based on 19 Reddit discussions
DULAGLUTIDE
50%
positive
12 threads
Metformin
43%
positive
7 threads
% of discussions mentioning each side effect
Based on 1 verified patient review
No data yet
No data yet
Avg. Duration
0 months
0% still taking
Avg. Duration
24 months
100% still taking
DULAGLUTIDE is a GLP-1 Agonist, while Metformin belongs to the Biguanide class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. DULAGLUTIDE is administered via Subcutaneous, whereas Metformin uses Oral. Route of administration can affect onset of action and patient adherence.
Metformin has an average efficacy rating of 8.0/10 and tolerability of 6.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..
DULAGLUTIDE carries 4 FDA warnings. Metformin carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.
Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.